029 Group SE

Delisting Announcement • Dec 22, 2006

News Details

Ad-hoc | 22 December 2006 12:45

Rhein Biotech N.V.: merger approved

Rhein Biotech N.V. / AGM/EGM/Merger

Ad hoc announcement according to § 15 WpHG transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

Maastricht, December 22, 2006

Merger Rhein Biotech N.V. with Crucell subsidiary approved

The general meeting of shareholders of Rhein Biotech N.V. held today
approved to effectuate the legal merger with a (directly and indirectly)
wholly owned subsidiary of Crucell N.V. Shareholders of Rhein Biotech N.V.
will in exchange for each share in Rhein Biotech N.V. receive 1.158 shares
in Crucell N.V.. After finalizing certain legal formalities the notarial
deed of merger will be executed on December 27, resulting in Rhein Biotech
N.V. ceasing to exist one day later and therefore its shares being delisted
from the Frankfurt stock exchange.

On December 28, the relevant number of Crucell N.V. shares will be
delivered to the persons holding Rhein Biotech N.V. shares at the end of
the last trading day (December 27, 2006), with any remaining fraction to be
settled in cash. For holders of bearer shares, such settlement will be
effected in a central way through the book-entry facilities of Clearstream
Banking A.G. and its participants. Shareholders do not have to take any
action themselves.

Please find below the timetable with the relevant key dates.

Date / Event

27 December 2006: Execution notarial deed of merger. The merger will take
effect one day after the execution of the deed of merger

27 December 2006: Last day of trading in Rhein Biotech N.V. shares on the
Frankfurt stock exchange

27 December 2006: (after close of trading): Record date for exchange of
Rhein Biotech N.V. shares into Crucell N.V. shares (with remaining fraction
to be settled in cash)

28 December 2006: Rhein Biotech N.V. ceases to exist

28 December 2006: Issuance and delivery of Crucell N.V. shares to eligible
holders of Rhein Biotech N.V. shares as of the record date (with remaining
fraction to be settled in cash)

For further information please see:www.rheinbiotech.com
(THL/CCK)

DGAP 22.12.2006

Language: English
Issuer: Rhein Biotech N.V.
Oude Maasstraat 47
6229 BC Maastricht Niederlande
Phone: +31 433 56 78 9-0
Fax: +31 433 56 78 9-9
E-mail: patrik.richard@bernabiotech.com
WWW: www.bernabiotech.com
ISIN: NL0000230324
WKN: 919544
Indices:
Listed: Geregelter Markt in Frankfurt (General Standard); Freiverkehr
in Berlin-Bremen, Stuttgart, München, Hamburg, Düsseldorf

End of News DGAP News-Service

---